How Prevalent are Non-Colorectal or Endometrial Cancers Among Individuals with Lynch Syndrome?
BACKGROUND AND PURPOSE:
- There is emerging evidence that Lynch Syndrome (LS) is associated with additional cancer types beyond colorectal and endometrial cancer
- Negro et al. (eClinicalMedicine, 2025) evaluated the incidence of non-colorectal/endometrial cancers in individuals with LS
METHODS:
- Retrospective cohort study
- Data derived from 2 centers in Italy
- Between 1995 and 2023
- Population
- Patients with LS
- Exposures
- Mismatch repair proteins (MMRs) immunohistochemistry detected gene mutations
- Study design
- Standardized incidence ratios (SIRs) were calculated, with adjustment for
- Age | Sex | Country
- Standardized incidence ratios (SIRs) were calculated, with adjustment for
- Primary outcome
- Cancer type
- Age at diagnosis
- Time to LS confirmation
RESULTS:
- 570 patients with LS
- Median age at diagnosis of LS: 50 (IQR, 38 to 61) years
- Malignancies detected
- Colorectal cancer: 44% of patients
- Endometrial cancer: 17% of patients
- Non-colorectal or endometrial cancer: 40%
- Most common types of non-colorectal/endometrial cancer
- Urothelial: 8%
- Breast: 8%
- Ovarian: 6%
- Gastric: 4%
- Cancers with the highest standardized incidence ratios
- Small intestine: SIR 10.54 (95% CI, 5.90 to 17.39)
- Urothelium/kidney: SIR 7.55 (95% CI, 5.42 to 10.24)
- Gastric: SIR 4.68 (95% CI, 2.90 to 7.16)
- Ovary: SIR 3.80 (95% CI, 2.32 to 5.87)
- Pancreas: SIR 3.09 (95% CI, 1.69 to 5.18)
- Patients diagnosed with non-colorectal/endometrial cancers before genetic testing: 11%
- Later developed colorectal or endometrial cancer: 46%
- Median time to onset
- Colorectal cancer: 10 (IQR, 5 to 15) years
- Endometrial cancer: 6 (IQR, 2 to 9) years
CONCLUSION:
- 40% of LS patients were diagnosed with a non-colorectal or endometrial cancer
- 11% of these diagnoses occurred before genetic testing
- The authors state
The spectrum of extracolonic malignancies linked to the syndrome is broader than previously recognized and differs significantly from the original descriptions
In addition to the well-established malignancies, a growing number of additional cancers are emerging as candidates for inclusion in LS spectrum
Learn More – Primary Sources:
Want to share this with your colleagues?
SPECIALTY AREAS
- Alerts
- Allergy And Immunology
- Cancer Screening
- Cardiology
- Cervical Cancer Screening
- COVID-19
- Dermatology
- Diabetes
- Endocrine
- ENT
- Evidence Matters
- General Internal Medicine
- Genetics
- Geriatrics
- GI
- GU
- Hematology
- ID
- Medical Legal
- Mental Health
- MSK
- Nephrology
- Neurology
- PcMED Connect
- PrEP for Patients
- PrEP for Physicians
- Preventive Medicine
- Pulmonary
- Rheumatology
- Vaccinations
- Women's Health
- Your Practice
